The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Open accessAbstract
BACKGROUND We predicted cancer mortality statistics for 2021 for the European Union (EU) and its five most populous countries plus the UK. We also focused on pancreatic cancer and female lung cancer. MATERIALS AND METHODS We obtained cancer death certifications and population data from the World Health Organization and Eurostat databases for 1970-2015. We predicted numbers of deaths and age-standardized (world population) rates for 2021 for total cancers and 10 major cancer sites, using a joinpoint regression model. We calculated the number of avoided deaths over the period 1989-2021. RESULTS We predicted 1,267,000 cancer deaths for 2021 in the EU, corresponding to age-standardized rates of 130.4/100,000 men (-6.6% since 2015) and 81.0 for women (-4.5%). We estimated further falls in male lung cancer rates, but still trending upward in women by +6.5%, reaching 14.5/100,000 in 2021. Breast cancer predicted rate in the EU was 13.3 (-7.8%). Rates for stomach and leukaemias in both sexes and for bladder in males are predicted to fall by over 10%; trends for other cancer sites were also favourable, except for pancreas, which showed stable patterns in both sexes, with predicted rates of 8.1/100,000 men and 5.6 for women. Rates for pancreas in EU men aged 25-49 and 50-64 declined, respectively, by 10% and 1.8%, while for those aged 65+ increased by 1.3%. Rates fell for young women only (-3.4%). Over 1989-2021, about 5 million cancer deaths were avoided in the EU27 compared with peak rates in 1988. CONCLUSION Overall cancer mortality continues to fall in both sexes. However, specific focus is needed on pancreatic cancer, which shows some hint of decline for young men only. Tobacco control remains a priority for the prevention of pancreatic and other tobacco-related cancers, which account for a third of the total EU cancer deaths, especially in women, who showed less favourable trends.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043828 · Cited by 447
Cited by
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
“With mortality rates reasonably stable in many countries (such as in the European Union countries 172 ) over the last decades, the disease has increased in its public health importance because of concomitant declines in mortality rates of other common cancers (e.g., lung, colorectal, prostate,…”
BackgroundDyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., Gavin, A., Flego, M., Neamtiu, L., Dimitrova, N., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.07.039 · Cited by 641
Oldacres, L., Hegarty, J., O'Regan, P., Murphy‐Coakley, N. M., & Saab, M. M. (2023) · Psycho-Oncology · doi:10.1002/pon.6073 · Cited by 36
Schulz, D., Heilmaier, M., Phillip, V., Treiber, M., Mayr, U., Lahmer, T., Mueller, J., Demir, I. E., Friess, H., Reichert, M., et al. (2023) · Endoscopy · doi:10.1055/a-1971-1274 · Cited by 29
Metadata
- Authors
- Carioli, G., Malvezzi, M., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., & Negri, E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 32
- Issue
- 4
- Pages
- 478-487
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W3132965430
- Cited by
- 168
- References
- 1
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. https://app.cochat.ai/papers/10.1016/j.annonc.2021.01.006
- The paper
- Carioli, G., Malvezzi, M., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., & Negri, E. (2021). European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Annals of Oncology. https://doi.org/10.1016/j.annonc.2021.01.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
